Follow on Telegram

News AI

OpenExample’s growth raises questions about advertising and medical AI accuracy

OpenEvidence is expanding as an advertising-supported AI service for doctors, with the company’s growth associated with a reported $15 billion valuation. The platform’s adoption suggests that clinicians are increasingly turning to AI tools for medical information and decision support.

The rise comes with unresolved questions about how reliably the system provides accurate information and how advertising affects the content doctors see. Those concerns are particularly important when AI-generated guidance is used in clinical settings, where precision and transparency matter.

Sources

Ars Technica: AI

Read next

US States Consider Pausing Data Center Expansion

Data center growth is coming under greater scrutiny from state governments across the United States. Bloomberg reports that approximately 40% of planned US data center capacity is in states whose governors want to pause or reconsider additional development. The proposed limits could affect a substantial share of planned expansion and

Voters Back AI Oversight and Limits on New Data Centers

Midterm voting produced two outcomes focused on the rapid expansion of artificial intelligence: voters elected watchdogs to oversee AI and approved ballot measures limiting new data centers. The results connect two closely related policy concerns. AI oversight concerns accountability for developing and deploying AI systems, while data-center restrictions address

Investors Question Anthropic's Proposed $1.5 Trillion IPO Valuation

Major investors are skeptical of Anthropic's plans to seek a $1.5 trillion valuation in an initial public offering. The reported doubts center on whether the artificial intelligence company can justify such a high market capitalization. A valuation of that scale would place exceptionally high expectations on the